NT_1170x120_1-11-18

Tosymra (sumatriptan) Nasal Spray

Upsher-Smith acquires two products from Dr. Reddy’s

Upsher-Smith acquires two products from Dr. Reddy’s

MAPLE GROVE, Minn. – Upsher-Smith recently announced that it has completed the acquisition of Tosymra (sumatriptan) Nasal Spray, 10 mg, and Zembrace SymTouch (sumatriptan) Injection 3 mg from Dr. Reddy’s Laboratories. The products were previously commercialized through Dr. Reddy’s wholly owned subsidiary, Promius Pharma. Both medications are indicated for the acute treatment of migraine with